Brokerages Anticipate Healthequity Inc (NASDAQ:HQY) Will Post Earnings of $0.20 Per Share

Analysts forecast that Healthequity Inc (NASDAQ:HQY) will announce $0.20 earnings per share for the current quarter, according to Zacks Investment Research. Seven analysts have issued estimates for Healthequity’s earnings. The highest EPS estimate is $0.32 and the lowest is $0.13. Healthequity posted earnings of $0.28 per share in the same quarter last year, which would indicate a negative year over year growth rate of 28.6%. The firm is scheduled to announce its next earnings report on Tuesday, December 3rd.

On average, analysts expect that Healthequity will report full year earnings of $1.20 per share for the current year, with EPS estimates ranging from $1.12 to $1.30. For the next year, analysts forecast that the business will post earnings of $1.36 per share, with EPS estimates ranging from $0.93 to $2.00. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research firms that cover Healthequity.

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 3rd. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.10. The company had revenue of $86.60 million during the quarter, compared to the consensus estimate of $85.33 million. Healthequity had a return on equity of 11.77% and a net margin of 28.13%. Healthequity’s revenue was up 21.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.36 earnings per share.

Several research firms have weighed in on HQY. Oppenheimer dropped their price target on Healthequity from $98.00 to $76.00 and set an “outperform” rating for the company in a research report on Wednesday, September 4th. Barrington Research reissued an “outperform” rating and set a $75.00 price target (down previously from $100.00) on shares of Healthequity in a research report on Wednesday, September 4th. Citigroup reissued a “buy” rating on shares of Healthequity in a research report on Friday, June 28th. Bank of America set a $79.00 price target on Healthequity and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, Raymond James raised Healthequity from an “outperform” rating to a “strong-buy” rating and dropped their price target for the stock from $90.00 to $80.00 in a research report on Monday, September 9th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $78.92.

In related news, VP Angelique Christine Hill sold 9,500 shares of Healthequity stock in a transaction on Friday, July 12th. The stock was sold at an average price of $71.40, for a total value of $678,300.00. Following the transaction, the vice president now owns 15,887 shares in the company, valued at $1,134,331.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jon Kessler bought 10,000 shares of Healthequity stock in a transaction that occurred on Friday, July 12th. The stock was purchased at an average price of $61.00 per share, for a total transaction of $610,000.00. Following the acquisition, the chief executive officer now directly owns 442,410 shares of the company’s stock, valued at approximately $26,987,010. The disclosure for this purchase can be found here. Insiders have sold 37,899 shares of company stock worth $2,711,131 in the last 90 days. Insiders own 3.70% of the company’s stock.

Institutional investors have recently modified their holdings of the stock. Meeder Asset Management Inc. acquired a new position in Healthequity in the second quarter valued at $25,000. BerganKDV Wealth Management LLC acquired a new position in Healthequity in the second quarter valued at $26,000. FTB Advisors Inc. acquired a new position in Healthequity in the second quarter valued at $27,000. Griffin Asset Management Inc. acquired a new position in Healthequity in the second quarter valued at $29,000. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. acquired a new position in Healthequity in the second quarter valued at $39,000. Hedge funds and other institutional investors own 83.65% of the company’s stock.

Healthequity stock traded up $0.01 during mid-day trading on Tuesday, hitting $54.54. 444,775 shares of the company were exchanged, compared to its average volume of 933,530. The company has a debt-to-equity ratio of 0.04, a current ratio of 22.98 and a quick ratio of 22.98. The business’s 50 day simple moving average is $58.81 and its two-hundred day simple moving average is $68.29. The company has a market capitalization of $3.85 billion, a P/E ratio of 57.41, a PEG ratio of 3.13 and a beta of 1.52. Healthequity has a 12-month low of $50.29 and a 12-month high of $101.58.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: What does an inverted yield curve signify?

Get a free copy of the Zacks research report on Healthequity (HQY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.